JPMorgan Chase & Co. Boosts Agilent Technologies (NYSE:A) Price Target to $190.00

Key Points

• JPMorgan raised Agilent Technologies’ price target from $180 to $190 and maintained an “overweight” rating, implying approximately 21% upside from the stock’s cited price.
• Agilent exceeded quarterly expectations, reporting $1.62 in EPS versus a $1.49 consensus estimate and revenue of $1.88 billion, up 8.1% year over year.
• Analysts collectively rate the stock “Moderate Buy,” with an average price target of $165.65; shares recently traded at $156.94, near their 52-week high of $163.75.

Agilent Technologies (NYSE:A - Get Free Report) had its price target lifted by research analysts at JPMorgan Chase & Co. from $180.00 to $190.00 in a research report issued on Thursday,Benzinga reports. The firm presently has an "overweight" rating on the medical research company's stock. JPMorgan Chase & Co.'s target price would suggest a potential upside of 21.06% from the company's current price.

A has been the subject of several other reports. Piper Sandler initiated coverage on shares of Agilent Technologies in a research note on Thursday, June 11th. They issued a "neutral" rating and a $150.00 target price for the company. Robert W. Baird increased their price target on shares of Agilent Technologies from $155.00 to $156.00 and gave the company an "outperform" rating in a research note on Tuesday, May 26th. Wolfe Research restated a "hold" rating on shares of Agilent Technologies in a research note on Tuesday, June 2nd. Wells Fargo & Company dropped their target price on shares of Agilent Technologies from $165.00 to $160.00 and set an "overweight" rating on the stock in a report on Thursday, May 28th. Finally, Weiss Ratings upgraded shares of Agilent Technologies from a "hold (c-)" rating to a "hold (c)" rating in a research note on Tuesday, June 2nd. One investment analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and four have assigned a Hold rating to the company. Based on data from MarketBeat, Agilent Technologies has an average rating of "Moderate Buy" and an average target price of $165.65.

Agilent Technologies Stock Up 1.2%

Shares of NYSE:A traded up $1.86 during midday trading on Thursday, reaching $156.94. The company had a trading volume of 1,643,520 shares, compared to its average volume of 2,230,675. The company has a quick ratio of 1.62, a current ratio of 2.10 and a debt-to-equity ratio of 0.43. The business's 50 day moving average price is $139.16 and its 200 day moving average price is $126.65. The stock has a market cap of $44.33 billion, a PE ratio of 31.48, a P/E/G ratio of 2.73 and a beta of 1.25. Agilent Technologies has a 1-year low of $108.35 and a 1-year high of $163.75.

Agilent Technologies (NYSE:A - Get Free Report) last issued its quarterly earnings results on Wednesday, August 26th. The medical research company reported $1.62 EPS for the quarter, beating the consensus estimate of $1.49 by $0.13. The firm had revenue of $1.88 billion during the quarter, compared to analysts' expectations of $1.84 billion. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.The business's quarterly revenue was up 8.1% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.37 earnings per share. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. Research analysts forecast that Agilent Technologies will post 6.05 EPS for the current fiscal year.

Hedge Funds Weigh In On Agilent Technologies

Several large investors have recently modified their holdings of A. Core Wealth Advisors LLC bought a new position in Agilent Technologies in the 4th quarter valued at about $26,000. SHP Wealth Management bought a new position in shares of Agilent Technologies during the fourth quarter worth approximately $26,000. Navalign LLC acquired a new stake in Agilent Technologies during the 4th quarter worth approximately $27,000. Cedar Mountain Advisors LLC acquired a new stake in Agilent Technologies during the 1st quarter worth approximately $27,000. Finally, Markowski Investments bought a new stake in Agilent Technologies in the 2nd quarter valued at $27,000. 87.41% of the stock is owned by institutional investors.

Trending Headlines about Agilent Technologies

Here are the key news stories impacting Agilent Technologies this week:

• Positive Sentiment: Quarterly results exceeded expectations: Agilent reported fiscal Q3 revenue of $1.88 billion, up 8.1% year over year and above the $1.84 billion consensus estimate. Adjusted EPS was $1.62 versus expectations of $1.49, while GAAP net income reached $362 million, or $1.28 per share, compared with $336 million a year earlier. Agilent Reports Third-Quarter Fiscal Year 2026 Financial Results
• Positive Sentiment: Improving demand and profitability supported the outlook: Management cited strengthening demand for laboratory tools used in research and drug development. Operating profit increased 23.3% to $444 million, and operating cash flow rose 43.4% to $519 million. Agilent raises annual profit forecast on improving lab tools demand
• Positive Sentiment: Fiscal-year guidance was raised above consensus: Agilent now expects fiscal 2026 adjusted EPS of $6.18-$6.21, versus the $6.06 analyst consensus, and revenue of approximately $7.5 billion, above the $7.4 billion estimate. Fourth-quarter EPS guidance of $1.71-$1.74 also brackets or exceeds consensus. Agilent Boosts FY View on Higher 3Q Profit, Revenue
• Positive Sentiment: Analysts became more constructive: TD Cowen and Sanford C. Bernstein raised their price targets to $180 and assigned Buy/Outperform ratings. RBC lifted its target to $185 and maintained an Outperform rating, implying roughly 14%-17% upside from recent trading levels. Analyst price-target revisions reported by Benzinga
• Neutral Sentiment: At approximately $157.85, Agilent is trading near its 52-week high, which may limit immediate upside despite the improved fundamental outlook and higher analyst targets.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company's product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source